Guinea

Section divider

Since 1993, improving health, saving lives and responding to disease outbreaks.

  • At Jhpiego-supported health care facilities, more than 426,000 deliveries were attended by a skilled birth attendant and more than 9 million women started using a modern family planning (FP) method for the first time.
  • The Health Service Delivery (HSD) project assisted Guinea’s Ministry of Health to define an integrated package of essential services and helped increase the number of facilities offering the full package from 79 in 2017) to 261 in 2022 (94% of project target).
  • To date, HSD has trained 117 providers, 143 community educators 30 paralegals and 50 protection officers in gender-based violence (GBV) services, including clinical management, referral and reporting, educational messages for prevention and awareness building of community resources. In the three years that HSD has supported GBV activities, more than 1600 cases have been managed at 56 project-supported facilities for this intervention.
  • Jhpiego supported COVID-19 vaccination in two regions, Boke and Kindia. Through support to organize and mobilize teams of vaccinators and ensure waste management, more than 2.3 million doses have been administered, with 1.04 million fully vaccinated with two doses or a single dose product. As a result, second dose coverage in these regions is 55% and 46%, respectively, of target—well exceeding the national average of 25%.

Our Work in Guinea

Under this USAID-funded project, Jhpiego and partners Engender Health and Save the Children are working closely with the Government of Guinea to ensure consistent and high-quality provision of an essential, integrated package of family planning and maternal and child health care at health facilities and in surrounding communities in seven target regions covering 85% of the population. The project objectives are: 1) delivery of quality health services improved through increased availability of services, referral linkages and quality of and access to services; 2) healthy behaviors and demand for high-quality health services improved through improved coordination, quality, targeting and scale of social and behavior change communication and health promotion activities; and 3) health systems strengthened through strengthened policy, planning, governance and human resources, and improved availability of commodities, drugs and data for decision-making. This project, originally for a five-year period, was extended to seven years, with additional focus on support for the implementation of the new community health strategy and COVID-19 response including vaccination (see below).

With additional funding from USAID under the Health Service Delivery project (above), Jhpiego is working in Guinea to address the COVID-19 pandemic. This work is designed to ensure that essential health services—and the health care provers who offer them—remain available and safe so that the community can access health care in facilities and in the community. Key activities include: 1) supporting facilities to set-up triage/screening services at their entrances; 2) reinforcing infection prevention and control measures of providers as well as hygiene/sanitation within facilities; 3) supporting community health workers to safely continue to provide health education and services; 4) reinforcing electronic communication capacity among health managers and with facilities; 5) supporting mass communication and social behavior change communication; 6) integrating COVID-19 case reporting into the national DHIS2 health information system; 7) ensuring ongoing engagement with the national pandemic coordination mechanism; and 8) supporting capacity building of reanimation services by building on previous support to pre-service education institutions.

Funded by the Bill & Melinda Gates Foundation, this program promotes access to family planning choices in West African countries by supporting the introduction and scale-up of subcutaneous depot-medroxyprogesterone acetate (DMPA-SC). DMPA-SC is an innovative injectable contraceptive—also known as Sayana® Press—that can dramatically expand access and choice for women. Jhpiego is working closely with the Access Collaborative to strengthen health systems to accelerate introduction and scale-up of DMPA-SC in select West African countries, including Guinea.

With funds from the Global Fund to Fight AIDS, Tuberculosis and Malaria, the Guinean Ministry of Health is supporting Jhpiego to strengthen and decentralize the national response to sexually transmitted infections, including HIV, with the goal of universal access to services. The goal of this program is to reduce new HIV infections and reduce the mortality and morbidity among people living with HIV. Jhpiego is leading the prevention of mother-to-child transmission of HIV (PMTCT) component of the program, focusing initially on consolidating gains and improving performance in PMTCT service provision followed by extension to additional sites.

 

This multi-country project is catalyzing the introduction and adoption pathways for quality-assured drugs to treat postpartum hemorrhage (i.e., heat-stable carbetocin, tranexamic acid and misoprostol) through engagement and coordination with country governments and key stakeholders. The project aims to reduce maternal mortality and morbidity by making sure the right drug is in the right place at the right time for the right indication. Funded by Unitaid, AMPLI-PPHI is led by Jhpiego and supported by consortium partners PATH and the International Federation of Gynaecology and Obstetrics (FIGO). In addition to operating in four target countries (the Democratic Republic of Congo, Guinea, Kenya and India), an additional 13 other influence countries are benefitting from country and learning exchanges as well as from the sharing of project learning, resources and tools. For more information, please visit the project website.